Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma
Abstract: Immunosuppressive drugs and biological agents may represent a potential risk of lymphoma development in patients with rheumatoid arthritis. But most cases are diffuse, large B-cell lymphomas. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma, a provisional entity in the...
Saved in:
Main Authors: | Han MA (Author), Shu Qiu (Author), Rongbiao Lu (Author), Peiying Feng (Author), Chun Lu (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurolymphomatosis in primary cutaneous CD4+ pleomorphic small/medium-sized T-cell lymphoma mimicking Hansen's disease
by: Anza Khader, et al.
Published: (2017) -
Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma in the practice of a dermatologist: A case report
by: Igor Kuklin, et al.
Published: (2021) -
Decrease of 5-hydroxymethylcytosine in primary cutaneous CD4+ small/medium sized pleomorphic T-cell lymphoproliferative disorder
by: Jiahui Hu, et al.
Published: (2024) -
An Atypical Presentation of Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder
by: Didem Kazan, et al.
Published: (2023) -
A case of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
by: Qingyu Hong, et al.
Published: (2023)